fangchinoline has been researched along with Conjunctival Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, K; Jia, R; Li, B; Li, J; Li, R; Li, Y; Mao, F; Shi, J; Wei, J; Yang, J; Zhu, J | 1 |
1 other study(ies) available for fangchinoline and Conjunctival Neoplasms
| Article | Year |
|---|---|
Fangchinoline suppresses conjunctival melanoma by directly binding FUBP2 and inhibiting the homologous recombination pathway.
Topics: Benzylisoquinolines; Conjunctival Neoplasms; Drugs, Chinese Herbal; Female; Homologous Recombination; Humans; Male; Melanoma | 2021 |